Compounds > 2,4-thiazolidinedione
Page last updated: 2024-08-16

2,4-thiazolidinedione and lg 100268

2,4-thiazolidinedione has been researched along with lg 100268 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirase, N; Mu, Y; Muta, K; Nawata, H; Takayanagi, R; Umemura, T; Yanase, T1
Breyer, MD; Breyer, RM; Davis, L; Guan, YF; Zhang, YH1
Cawthorne, MA; Emilsson, V; Heyman, R; Liu, YL; O'Dowd, J; Sennitt, M; Wang, S1
Blows, F; O'Rahilly, S; Sewter, CP; Vidal-Puig, A1

Other Studies

4 other study(ies) available for 2,4-thiazolidinedione and lg 100268

ArticleYear
Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60.
    Oncology, 1999, Volume: 57 Suppl 2

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Differentiation; Chromans; Drug Synergism; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Monocytes; Nicotinic Acids; Proto-Oncogene Proteins; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Troglitazone

1999
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Neoplasia (New York, N.Y.), 1999, Volume: 1, Issue:4

    Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins; Cell Death; Chromans; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; G1 Phase; Humans; Immunoblotting; In Situ Hybridization; Ligands; Luciferases; Myelin P2 Protein; Neoplasm Proteins; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Ribonucleases; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms

1999
The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:12

    Topics: Adipose Tissue, Brown; Animals; Body Weight; Carrier Proteins; Eating; Ion Channels; Membrane Proteins; Membrane Transport Proteins; Mitochondrial Proteins; Nicotinic Acids; Obesity; Proteins; Rats; Rats, Zucker; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Uncoupling Protein 1; Uncoupling Protein 2; Uncoupling Protein 3; Weight Gain

2000
Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists.
    Diabetes, 2002, Volume: 51, Issue:3

    Topics: Adipocytes; Adult; Aged; Cell Differentiation; Female; Gene Expression; Humans; Hypoglycemic Agents; Ligands; Male; Middle Aged; Nicotinic Acids; Omentum; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Skin; Stem Cells; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors

2002